Corbus Pharmaceuticals Holdings, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$3.51 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2021-11-12
- Corbus Pharmaceuticals Holdings, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-09-30 was -$3.51K.
- Corbus Pharmaceuticals Holdings, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-06-30 was $23.31K.
- Corbus Pharmaceuticals Holdings, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-03-31 was -$28.77K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month |
|---|---|---|---|
| 2021-09-30 | -$3.51K 10-Q · filed 2021-11-12 | $19.80K derived: sum of 2 quarters · filed 2021-11-12 | -$8.97K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.31K 10-Q · filed 2021-08-12 | -$5.45K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$28.77K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |